revers
transcript
polymeras
chain
reaction
rtpcr
realtim
quantit
revers
transcript
polymeras
chain
reaction
qrtpcr
assay
wide
use
method
detect
quantif
rna
virus
detect
method
base
rtpcr
rapidli
replac
qrtpcr
method
nowaday
consid
gold
standard
detect
quantif
rna
virus
vermehren
et
al
qrtpcr
base
method
pcr
develop
mulli
et
al
saiki
et
al
invent
realtim
pcr
qpcr
earli
allow
monitor
cours
pcr
reaction
real
time
ad
dimens
nucleic
acid
quantif
microbi
diagnost
higuchi
et
al
higuchi
et
al
logic
evolut
pcr
method
also
wit
combin
initi
rt
step
qpcr
led
establish
qrtpcr
power
assay
analysi
rna
molecul
comparison
method
detect
rna
virus
among
cell
cultur
method
widespread
qrtpcr
mani
advantag
propag
virus
use
cell
cultur
method
timeconsum
process
viru
type
andor
even
strain
differ
characterist
furthermor
detect
problemat
case
virus
grown
convent
cell
cultur
eg
human
noroviru
nov
hepat
e
viru
hev
barnaud
et
al
rodriguez
et
al
hand
qrtpcr
capabl
detect
ten
genom
copi
viral
nucleic
acid
sampl
puig
et
al
although
qrtpcr
wide
use
nowaday
still
perfect
detect
method
main
disadvantag
lie
inabl
distinguish
infecti
noninfecti
viral
particl
also
necessari
strictli
control
step
qrtpcr
analysi
rna
virus
use
system
neg
posit
control
would
guarante
valid
result
rt
step
extrem
unpredict
need
monitor
effici
rt
step
averag
vari
within
differ
qrtpcr
protocol
also
qrtpcr
experi
curri
et
al
falseneg
result
may
caus
wide
rang
differ
factor
presenc
inhibit
substanc
sampl
incorrect
composit
enzym
mixtur
poor
activ
revers
transcriptas
dna
polymeras
thermal
cycler
failur
also
failur
first
step
viral
rna
extract
nucleic
acid
nucleic
acid
extract
step
crucial
point
molecular
biolog
analysi
therefor
must
strict
control
mani
reagent
tradit
use
isol
nucleic
acid
chelat
compound
deterg
guanidium
hydrochlorid
inhibit
enzymat
reaction
monteiro
et
al
inhibitori
substanc
complex
polysaccharid
phenol
organ
compound
metabol
product
also
natur
present
sampl
partial
complet
inhibit
rt
andor
pcr
abu
alsoud
et
al
da
et
al
wilson
schrader
et
al
also
work
lowqual
nucleic
acid
strongli
affect
experiment
result
quantiti
qualiti
may
vari
due
degrad
nucleic
acid
especi
rna
isol
storag
process
therefor
everi
nucleic
acid
prepar
assess
qualiti
quantiti
fleig
pfaffl
addit
detect
rna
sensit
complic
process
detect
dna
especi
need
revers
transcrib
rna
prevent
contamin
ribonucleas
stabil
nucleic
acid
depend
abil
resist
action
ubiquit
nucleas
dnase
ribonucleas
dnase
easili
heatinactiv
ribonucleas
withstand
high
temperatur
even
increas
pressur
stabl
differ
condit
extrem
ph
spackman
et
al
zale
klibanov
reason
inappropri
use
synthet
rna
construct
rna
transcrib
vitro
refer
rna
pool
control
nucleic
acid
extract
step
also
plasmid
dna
although
stabl
rna
repres
authent
templat
rt
procedur
cartwright
past
author
describ
method
increas
stabil
rna
presenc
ribonucleas
shown
chemic
modif
phosphat
modif
black
et
al
modif
ribos
pieken
et
al
contribut
stabil
rna
molecul
although
modif
increas
resist
rna
ribonucleas
practic
exampl
use
modifi
rna
molecul
control
materi
anoth
potenti
method
ensur
rna
stabil
presenc
ribonucleas
util
rna
secondari
structur
chen
et
al
control
gc
rich
rodlik
rna
molecul
extens
secondari
structur
base
modifi
hepat
delta
viru
hdv
genom
test
shown
exhibit
enhanc
stabil
resist
ribonucleas
dingl
et
al
howev
major
disadvantag
approach
extens
secondari
structur
selfstabil
effect
togeth
high
gc
content
make
molecul
difficult
templat
rt
pcr
therefor
control
nucleic
acid
extract
step
gener
involv
util
nonpathogen
control
protect
control
rna
molecul
insid
capsid
mimic
target
viru
extract
step
analyz
sampl
spike
prior
process
defin
amount
process
control
viru
control
rna
insid
capsid
extract
togeth
target
rna
approach
allow
control
effici
rna
extract
concentr
step
remov
rt
pcr
inhibitor
whole
qrtpcr
assay
current
mani
differ
process
control
virus
use
detect
rna
virus
see
next
chapter
phagelik
particl
repres
one
type
process
control
virus
use
technolog
product
phagelik
particl
possibl
construct
process
control
virus
technolog
product
phagelik
particl
theoret
well
establish
use
knowledg
gain
studi
familiar
bacteriophag
util
mani
differ
approach
construct
variou
process
control
virus
nevertheless
practic
use
technolog
routin
diagnost
rel
uncommon
aim
present
review
provid
insight
current
use
process
control
virus
rtpcr
qrtpcr
detect
rna
virus
focus
possibl
use
phagelik
particl
current
knowledg
regard
possibl
phagelik
particl
prepar
util
discuss
use
process
control
viru
detect
virus
food
matric
necessari
fig
european
committe
standard
cen
releas
iso
technic
specif
isot
isot
isot
method
determin
hav
nov
food
use
qrtpcr
requir
use
process
control
viru
qrtpcr
detect
virus
accord
technic
specif
cultiv
nonenvelop
positivesens
singlestrand
rna
ssrna
viru
shall
use
control
isot
isot
furthermor
process
control
viru
similar
size
target
viru
provid
good
morpholog
physicochem
model
genet
distinct
form
target
viru
avoid
crossreact
natur
present
analyz
sampl
abovement
isot
standard
recommend
use
genet
modifi
mengoviru
process
control
viru
detect
quantif
hav
nov
costafreda
et
al
le
guyad
et
al
butot
et
al
mengoviru
murin
viru
picornavirida
famili
viru
structur
physicochem
properti
close
hav
nov
nonenvelop
viru
singlestrand
rna
resist
properti
environ
close
target
virus
use
type
matric
genet
modifi
mengo
viru
strain
recombin
viru
lack
poli
c
tract
thu
avirul
phenotyp
martin
et
al
growth
properti
strain
ident
wildtyp
viru
strain
genet
modifi
organ
gmo
thu
recommend
laboratori
use
gmo
prohibit
problemat
differ
process
control
viru
use
qrtpcr
assay
isot
literatur
mani
exampl
use
process
control
virus
nishida
et
al
use
echo
type
viru
process
control
viru
qrtpcr
detect
nov
oyster
nishida
et
al
murin
noroviru
use
process
control
viru
qrtpcr
detect
hav
lettuc
coudray
et
al
semidri
tomato
martinlatil
et
al
nov
bottl
tap
water
hennechartcollett
et
al
felin
caliciviru
fcv
use
process
control
viru
qrtpcr
detect
hav
caliciviru
bottl
natur
miner
water
di
pasqual
et
al
mattison
et
al
even
suggest
fcv
becom
standard
process
control
viru
method
aim
extract
detect
rna
virus
food
water
matric
mattison
et
al
howev
comparison
whole
genom
sequenc
differ
strain
fcv
show
high
genet
divers
rel
target
site
qrtpcr
primer
probe
design
coyn
et
al
radford
et
al
case
primer
probe
detect
target
virus
interact
detect
fcv
fcv
use
process
control
viru
also
anoth
nonhuman
miguel
sea
lion
viru
serogroup
use
process
control
viru
qrtpcr
detect
hav
nov
oyster
depaola
et
al
natur
rna
virus
resist
ribonucleas
allow
control
decapsul
rna
extract
disadvantag
virus
pathogen
virus
easili
access
privat
compani
moreov
routin
laboratori
equip
cultiv
virus
therefor
abl
maintain
steadi
suppli
process
control
viru
anoth
interest
exampl
literatur
relat
process
control
virus
describ
use
bacteriophag
purpos
wildtyp
bacteriophag
use
process
control
viru
qrtpcr
detect
hav
food
water
matric
blaiseboisseau
et
al
success
test
qrtpcr
assay
detect
quantif
viral
pathogen
eg
nov
gi
gii
rolf
et
al
data
show
bacteriophag
offer
reliabl
simpl
way
monitor
nucleic
acid
extract
step
make
valuabl
tool
routin
diagnost
laboratori
moreov
wildtyp
bacteriophag
also
use
process
control
viru
evalu
differ
system
isol
viral
rna
estim
amount
copurifi
inhibitor
qrtpcr
shulman
et
al
cultiv
bacteriophag
much
easier
anim
rna
virus
requir
addit
special
laboratori
equip
comparison
pathogen
anim
rna
virus
wildtyp
bacteriophag
constitut
safeti
problem
laboratori
personnel
use
still
two
major
disadvantag
first
wildtyp
bacteriophag
abil
prolifer
theoret
specif
sampl
fecal
contamin
natur
contain
escherichia
coli
bacteriophag
prolifer
exceed
number
detect
pathogen
rna
virus
present
sampl
second
wildtyp
bacteriophag
use
competit
process
control
viru
genom
contain
specif
target
sequenc
one
possibl
solut
problem
would
product
recombin
bacteriophag
carri
genom
sequenc
serv
target
establish
detect
method
howev
product
viabl
recombin
infecti
bacteriophag
would
serv
competit
process
control
viru
reject
sever
reason
paslosk
et
al
main
obstacl
recombin
bacteriophag
genet
stabl
heterolog
sequenc
quickli
delet
final
rna
replicas
fidel
poor
thu
high
number
point
mutat
delet
could
introduc
target
sequenc
therefor
recombin
bacteriophag
suitabl
competit
process
control
viru
howev
use
technolog
product
phagelik
particl
possibl
creat
genet
stabl
homogen
process
control
viru
carri
specif
control
rna
sequenc
insid
capsid
use
process
control
viru
rtpcr
qrtpcr
detect
rna
virus
clinic
specimen
necessari
far
isot
would
describ
use
specif
process
control
virus
case
food
matric
differ
type
process
control
virus
use
clinic
specimen
cleland
et
al
use
bovin
viral
diarrhea
viru
bvd
process
control
viru
rtpcr
detect
hcv
blood
cleland
et
al
fcv
use
process
control
viru
food
water
matric
also
use
qrtpcr
detect
hev
form
swine
fecal
blood
sampl
ward
et
al
wildtyp
bacteriophag
success
use
process
control
viru
qrtpcr
detect
hcv
blood
donor
screen
dreier
et
al
also
chidlow
et
al
use
bacteriophag
control
process
viru
monitor
effici
sampl
extract
remov
rt
pcr
inhibitor
cdna
product
qrtpcr
detect
pandem
season
influenza
b
virus
deep
nasal
throat
swab
chidlow
et
al
also
phagelik
particl
use
process
control
viru
detect
pathogen
rna
virus
clinic
sampl
exampl
paslosk
et
al
prepar
phagelik
particl
also
call
armor
rna
arna
carri
consensu
rna
sequenc
human
immunodefici
viru
type
packag
capsid
serv
quantit
standard
detect
paslosk
et
al
beld
et
al
use
phagelik
particl
carri
noncod
region
enteroviru
ev
process
viru
control
detect
human
enterovirus
beld
et
al
phagelik
particl
contain
primer
bind
site
detect
enterovirus
differ
probe
region
phagelik
particl
carri
plantspecif
carboxyl
small
subunit
rbc
gene
fragment
use
process
control
viru
qrtpcr
detect
sever
acut
respiratori
syndrom
coronaviru
sarscov
cheng
et
al
phagelik
particl
also
use
process
control
viru
qrtpcr
screen
hcv
blood
donor
meng
li
studi
confirm
phagelik
particl
suitabl
process
control
virus
detect
rna
virus
clinic
specimen
packag
system
nonbacteriophag
rna
base
ci
mechan
sequenc
coat
protein
maturas
stemloop
contain
control
sequenc
local
rna
molecul
recombin
rna
rerna
elimin
problem
overproduct
coat
protein
thu
problem
nonspecif
packag
rna
molecul
duboi
et
al
socal
plasmiddriven
packag
system
base
vector
contain
maturas
coat
protein
bacteriophag
sequenc
togeth
target
rna
sequenc
contain
stemloop
sequenc
clone
downstream
induc
lac
promot
fig
presenc
maturas
gene
vector
mandatori
howev
presenc
capsid
stabil
whole
structur
contribut
ribonucleas
resist
strategi
use
highfidel
e
coli
rna
polymeras
transcrib
clone
sequenc
rerna
use
iptg
induct
coat
protein
translat
bind
stemloop
sequenc
initi
packag
rernacontain
control
sequenc
phagelik
particl
express
vector
contain
lysi
replicas
gene
bacteriophag
essenti
assembl
bacteriophag
capsid
phagelik
particl
local
cytoplasm
e
coli
length
rerna
wrap
phagelik
particl
repres
one
import
paramet
oneplasmid
packag
system
howev
first
studi
use
system
de
novoconstruct
nt
rna
fragment
packag
phagelik
particl
paslosk
et
al
author
packag
nt
rna
fragment
use
oneplasmid
packag
system
walkerpeach
et
al
suggest
icosahedr
structur
bacteriophag
capsid
maxim
size
rerna
packag
theoret
around
kb
total
duboi
et
al
kb
reserv
bacteriophag
sequenc
encod
maturas
coat
protein
stemloop
structur
therefor
kb
dedic
control
rerna
sequenc
defin
maximum
size
rerna
packag
construct
design
packag
bacteriophag
rna
sequenc
differ
size
creat
paslosk
et
al
found
construct
encod
kb
bacteriophag
rna
contain
rerna
expect
size
postul
effici
packag
decreas
quickli
size
rerna
increas
beyond
nt
later
huang
et
al
tri
directli
packag
nt
control
rerna
sequenc
huang
et
al
phagelik
particl
contain
entir
nt
control
sequenc
success
assembl
found
delet
dispos
sequenc
multipl
clone
site
transcript
termin
abl
increas
packag
capac
origin
vector
without
affect
packag
effici
far
largest
target
rna
could
packag
nt
use
one
stemloop
wildtyp
sequenc
rerna
presenc
stemloop
sequenc
rerna
also
composit
crucial
format
phagelik
particl
shown
substitut
c
stemloop
structur
increas
affin
coat
protein
rerna
sixfold
even
high
wildtyp
stemloop
lago
et
al
stockley
et
al
lecuy
et
al
romaniuk
uhlenbeck
horn
et
al
talbot
et
al
lowari
uhlenbeck
stockley
et
al
also
confirm
presenc
second
stemloop
structur
enabl
cooper
bind
coat
protein
dimer
rerna
result
higher
affin
compar
singl
stemloop
structur
pickett
peabodi
witherel
et
al
wei
et
al
construct
nt
chimer
control
rerna
sequenc
contain
two
variant
stemloop
structur
order
explor
whether
rerna
longer
nt
could
packag
use
oneplasmid
packag
system
wei
et
al
demonstr
rerna
length
nt
packag
coat
protein
util
oneplasmid
packag
system
two
variant
stemloop
structur
also
show
vector
two
variant
stemloop
structur
exhibit
highest
express
effici
therefor
maxim
length
rerna
packag
use
oneplasmid
packag
system
around
nt
twoplasmid
packag
system
develop
order
packag
sequenc
longer
nt
packag
use
oneplasmid
packag
system
twoplasmid
packag
system
maturas
coat
protein
express
one
plasmid
vector
target
control
rna
sequenc
modifi
stemloop
structur
transcrib
anoth
plasmid
vector
fig
wei
et
al
first
studi
nonbacteriophag
rna
encapsid
pickett
peabodi
use
twoplasmid
packag
system
pickett
peabodi
howev
system
lack
specif
due
inabl
determin
appropri
ratio
coat
protein
stemlooplacz
rna
system
design
wei
et
al
differ
pickett
peabodi
system
sever
way
wei
et
al
bacteriophag
sequenc
locat
first
plasmid
pickett
peabodi
system
consist
coat
protein
sequenc
pickett
peabodi
contrast
system
wei
et
al
addit
maturas
sequenc
first
plasmid
wei
et
al
maturas
protein
import
compon
phagelik
particl
presenc
requir
protect
integr
rna
effect
ribonucleas
argetsing
gussin
heisenberg
addit
maturas
protein
interact
specif
phage
rna
two
site
shiba
suzuki
may
therefor
play
substanti
role
packag
anoth
differ
wei
et
al
chose
two
lowcopi
plasmid
almost
equival
copi
number
contain
bacteriophag
promot
wei
et
al
given
equival
ratio
coat
protein
target
rna
stemloop
sequenc
appropri
moreov
target
rna
sequenc
contain
variant
stemloop
structur
increas
affin
coat
protein
dimer
target
rna
biggest
differ
twoplasmid
packag
system
oneplasmid
packag
system
phagelik
particl
produc
twoplasmid
packag
system
contain
control
rna
sequenc
without
bacteriophag
sequenc
advantag
use
control
rna
sever
kb
length
long
sequenc
encompass
multipl
target
control
sequenc
varieti
detect
virus
accordingli
necessari
construct
differ
phagelik
particl
contain
control
diagnost
assay
multipl
control
differ
research
group
clinic
laboratori
could
directli
compar
quantit
data
use
twoplasmid
packag
system
wei
et
al
abl
packag
sequenc
nt
length
wei
et
al
theoret
length
packag
rna
use
twoplasmid
packag
system
could
reach
approxim
kb
sinc
bacteriophag
genom
nt
length
author
also
tri
packag
nt
long
sequenc
success
conclus
twoplasmid
packag
system
use
effect
packag
sequenc
longer
nt
oneplasmid
doubleexpress
packag
system
repres
latest
advanc
system
packag
differ
rna
sequenc
phagelik
particl
zhan
et
al
comparison
twoplasmid
packag
system
oneplasmid
doubleexpress
system
disadvantag
lower
express
effici
necessari
sequenc
packag
control
sequenc
locat
one
plasmid
vector
oneplasmid
doubleexpress
system
consist
one
plasmid
vector
two
clone
site
control
two
bacteriophag
promot
fig
like
case
twoplasmid
packag
system
phagelik
particl
produc
use
oneplasmid
doubleexpress
packag
system
contain
defin
control
rna
sequenc
without
bacteriophag
sequenc
wrap
control
rna
contain
variant
stemloop
structur
ensur
recognit
coat
protein
dimer
encapsid
arrang
ensur
mainten
optim
ratio
maturas
coat
protein
stemloop
contain
rna
control
sequenc
zhan
et
al
use
oneplasmid
doubleexpress
packag
system
packag
control
rna
sequenc
nt
length
contain
three
stemloop
structur
zhan
et
al
zhan
et
al
also
discuss
enhanc
packag
effici
observ
induc
increas
number
stemloop
structur
zhan
et
al
assum
may
due
one
follow
mechan
first
initi
complex
abl
form
quickli
stabl
increas
number
stemloop
structur
johansson
et
al
valegard
et
al
thu
trigger
packag
effici
second
initi
complex
promot
continu
packag
higher
effici
higher
rate
valegard
et
al
toropova
et
al
third
presenc
second
stemloop
structur
presum
make
two
coat
protein
dimer
bind
rna
cooper
manner
result
higher
affin
lower
sensit
ph
ionic
strength
temperatur
rna
singl
stemloop
structur
pickett
peabodi
witherel
et
al
plasmiddriven
packag
system
base
product
phagelik
particl
vivo
protocol
suitabl
e
coli
strain
eg
e
coli
strain
transform
recombin
vector
bear
necessari
sequenc
product
phagelik
particl
product
induc
addit
iptg
e
coli
cultur
subsequ
phagelik
particl
assembl
spontan
cytoplasm
bacteria
understand
natur
assembl
process
use
product
phagelik
particl
vitro
vitro
synthesi
phagelik
particl
contain
sequenc
choic
possibl
wildtyp
phagelik
capsid
disassembl
treatment
acet
acid
reassembl
presenc
varieti
stemloop
structurecontain
rna
molecul
simpli
rais
ph
toward
neutral
sugiyama
nakada
stockley
et
al
sugiyama
nakada
comparison
vivo
product
phagelik
particl
effici
fidel
vitro
reaction
lower
optim
reaction
difficult
thu
phagelik
particl
use
process
control
virus
rtpcr
qrtpcr
synthes
mostli
vivo
vitro
system
product
phagelik
particl
current
find
applic
method
target
drug
deliveri
wu
et
al
mastico
et
al
wu
et
al
brown
et
al
galaway
stockley
li
et
al
process
control
virus
stabl
longterm
storag
stabil
depend
especi
abil
resist
action
ubiquit
nucleas
paslosk
et
al
demonstr
rerna
packag
within
phagelik
particl
complet
resist
dnase
ribonucleas
treatment
condit
nake
dna
rna
degrad
rapidli
paslosk
et
al
stabil
find
phagelik
particl
consist
author
song
et
al
beld
et
al
hietala
crossley
wei
et
al
walkerpeach
et
al
yu
et
al
zhan
et
al
result
demonstr
high
stabil
durabl
phagelik
particl
differ
storag
condit
express
vector
product
phagelik
particl
contain
lysi
gene
essenti
assembl
bacteriophag
capsid
therefor
phagelik
particl
local
cytoplasm
e
coli
must
releas
enzymat
lysozym
duboi
et
al
mechan
ultrason
disrupt
bacteri
cell
cheng
et
al
wei
et
al
b
zhan
et
al
yu
et
al
howev
major
problem
current
phagelik
prepar
purif
procedur
like
bacteriophag
phagelik
particl
purifi
use
tradit
cscl
gradient
ultracentrifug
band
tightli
concentr
pickett
peabodi
howev
procedur
labori
expens
ultracentrifug
sucros
gradient
also
use
isol
phagelik
particl
particl
local
sucros
densiti
layer
cheng
et
al
yu
et
al
use
electroelut
phagelik
particl
agaros
gel
gebaflex
tube
yu
et
al
compar
purif
phagelik
particl
use
tradit
cscl
fraction
method
electroelut
effici
easi
perform
order
solv
problem
purif
procedur
recombin
plasmid
vector
express
phagelik
particl
harbor
affin
tag
polyhistidinetag
surfac
capsid
construct
cheng
et
al
allow
isol
extrem
pure
phagelik
particl
affin
chromatographi
enhanc
purif
procedur
base
find
foreign
peptid
may
present
surfac
bacteriophag
capsid
mastico
et
al
coat
protein
subunit
conserv
antiparallel
topolog
seen
everi
spheric
rna
viru
coat
protein
structur
rossmann
johnson
rather
coat
protein
bacteriophag
capsid
packag
form
noncoval
dimer
secur
interdigit
ctermin
monom
underneath
helic
lie
extens
compris
five
subunit
wherea
nterminu
protein
polypeptid
fold
structur
protrud
surfac
bacteriophag
capsid
mastico
et
al
thu
found
insert
foreign
peptid
sequenc
top
structur
lead
aberr
fold
bacteriophag
capsid
howev
foreign
peptid
sequenc
must
insert
specif
posit
coat
protein
sequenc
avoid
detriment
effect
phage
capsid
assembl
posit
locat
residu
coat
protein
amino
acid
sequenc
foreign
peptid
sequenc
insert
posit
use
method
sitedirect
mutagenesi
sayer
et
al
heal
et
al
adenin
posit
sequenc
coat
protein
replac
thymin
thymin
posit
replac
cytosin
chang
lead
creation
kpni
restrict
enzym
cleavag
site
posit
sequenc
coat
protein
without
chang
amino
acid
sequenc
foreign
protein
sequenc
clone
kpni
restrict
enzym
cleavag
site
method
foreign
peptid
sequenc
insert
caus
duplic
codon
glycin
threonin
posit
coat
protein
thu
lead
insert
flank
sequenc
glythr
mastico
et
al
cheng
et
al
use
system
produc
histag
phagelik
particl
easili
purifi
use
affin
chromatographi
fig
cheng
et
al
tri
fail
insert
streptag
tat
intact
phagelik
particl
obtain
comparison
phagelik
particl
purifi
use
gradient
ultracentrifug
affinitypurifi
phagelik
particl
extrem
pure
use
method
affin
chromatographi
greatli
simplifi
reduc
cost
purifi
phagelik
particl
transmiss
electron
microscopi
tem
direct
method
count
viral
particl
success
use
determin
concentr
phagelik
particl
borsheim
et
al
howev
long
analysi
time
requir
well
high
cost
difficulti
method
led
develop
altern
method
one
major
advantag
phagelik
particl
abl
replic
hand
major
advantag
also
disadvantag
regard
enumer
phagelik
particl
form
plaqu
therefor
number
easili
determin
use
convent
plaqu
assay
reason
author
use
indirect
method
determin
number
phagelik
particl
number
phagelik
particl
may
determin
use
avogadro
constant
extinct
coeffici
mgml
bacteriophag
molecular
weight
cheng
et
al
wei
et
al
duboi
et
al
base
procedur
approxim
phagelik
particl
purifi
count
l
e
coli
product
cultur
duboi
et
al
yu
et
al
case
phagelik
particl
contain
sequenc
detect
commerci
avail
kit
use
accur
quantif
viral
load
sampl
kit
also
use
quantif
phagelik
particl
paslosk
et
al
use
kit
quantif
phagelik
particl
contain
nt
hiv
gag
sequenc
sequenc
serv
target
primer
use
kit
paslosk
et
al
exampl
quantif
phagelik
particl
use
commerci
kit
quantif
phagelik
particl
contain
nearli
full
length
hiv
pol
gene
packag
sequenc
use
versant
rna
assay
zhan
et
al
quantif
phagelik
particl
contain
nt
target
consensu
sequenc
use
hcv
kit
primer
walkerpeach
et
al
determin
number
isol
phagelik
particl
import
set
qrtpcr
reaction
entir
nucleic
acid
extract
procedur
excess
number
process
control
virus
caus
inhibit
convers
low
amount
may
caus
problem
detect
limit
exact
number
ad
process
control
virus
must
evalu
individu
detect
quantit
method
howev
found
number
phagelik
process
control
virus
approxim
copiesml
neglig
influenc
target
amplif
cheng
et
al
therefor
commerci
avail
phagelik
particl
also
offer
number
approxim
copiesml
discuss
previou
section
product
isol
purif
quantif
phagelik
particl
requir
knowledg
differ
laboratori
method
requir
laboratori
expertis
sophist
equip
may
discourag
mani
laboratori
produc
phagelik
particl
routin
use
process
control
viru
diagnost
method
base
rtpcr
qrtpcr
laboratori
possibl
purchas
phagelik
particl
commerci
compani
soon
public
first
articl
describ
technolog
product
phagelik
particl
wish
express
process
control
virus
commerci
avail
soon
possibl
cartwright
asuragen
compani
current
offer
phagelik
particl
diagnost
use
trade
mark
armoredrna
control
use
rna
extract
amplif
detect
calibr
control
new
assay
develop
type
control
avail
use
rtpcr
detect
system
hiv
subtyp
b
mulder
et
al
hcv
genotyp
young
et
al
hepat
g
viru
hgv
schlueter
et
al
nov
gi
gii
ando
et
al
west
nile
viru
bries
et
al
bries
et
al
lanciotti
et
al
dengu
viru
type
sudiro
et
al
enteroviru
schwab
et
al
rotbart
sar
drosten
et
al
sar
covnc
emeri
et
al
armoredrna
control
purchas
specifi
number
phagelik
particl
per
volum
unit
copiesml
therefor
util
process
control
virus
establish
standard
curv
qrtpcr
number
particl
lottolot
consist
type
control
use
qrtpcr
detect
quantif
system
hiv
subtyp
b
mulder
et
al
hcv
genotyp
young
et
al
enteroviru
schwab
et
al
rotbart
detect
molecular
marker
chronic
myeloid
leukemia
bcrabl
burmeist
et
al
commerci
avail
control
design
mostli
like
competit
control
compat
commerci
kit
like
quant
human
immunodefici
viru
subtyp
b
kit
quant
hepat
c
viru
genotyp
hcv
kit
rang
commerci
avail
phagelik
particl
offer
wide
produc
use
oneplasmid
packag
system
mean
maximum
length
packag
control
rerna
exceed
nt
paslosk
et
al
walkerpeach
et
al
thu
clear
commerci
avail
control
util
rtpcr
qrtpcrbase
detect
assay
specif
requir
control
sequenc
moreov
cost
commerci
produc
phagelik
particl
rel
high
especi
case
quant
product
howev
anyon
skill
field
rel
cheapli
produc
huge
amount
phagelik
particl
strictli
defin
control
sequenc
design
accord
hisher
need
isot
isot
recommend
use
genet
modifi
mengoviru
process
control
viru
detect
hav
nov
food
matric
costafreda
et
al
le
guyad
et
al
butot
et
al
genet
modifi
mengoviru
bought
ceeram
tool
corp
exclus
licens
qrtpcr
mengoviru
detect
system
mengo
extract
kit
contain
genet
modifi
mengoviru
isol
cell
cultur
number
copi
mengoviru
depend
batch
number
lottolot
number
consist
case
armoredrna
product
mengo
extract
kit
design
rapid
estim
rna
extract
effici
appropri
use
process
control
virus
rtpcr
qrtpcr
detect
quantif
rna
virus
differ
matric
critic
point
sampl
analysi
use
process
control
virus
enabl
monitor
whole
process
sampl
analysi
includ
nucleic
acid
extract
step
bacteriophag
phagelik
particl
wide
use
control
whole
process
sampl
prepar
includ
rna
isol
particular
phagelik
particl
repres
suitabl
process
control
virus
detect
rna
virus
moreov
process
control
virus
base
phagelik
particl
use
routin
clinic
diagnost
vast
number
virus
key
featur
particl
abil
protect
control
rna
contain
degrad
ubiquit
ribonucleas
noninfect
longterm
storag
stabil
differ
condit
inabl
replic
possibl
pack
specif
control
sequenc
rel
simplic
phagelik
particl
prepar
possibl
plasmiddriven
packag
system
abil
pack
ssrna
variabl
length
cheap
fast
capabl
produc
huge
quantiti
also
signific
advantag
phagelik
particl
situat
regard
util
phagelik
particl
process
control
virus
detect
rna
virus
food
matric
differ
scenario
clinic
diagnost
literatur
report
phagelik
particl
use
process
control
virus
detect
rna
virus
food
matric
wildtyp
bacteriophag
use
purpos
blaiseboisseau
et
al
rolf
et
al
shulman
et
al
result
show
bacteriophag
repres
reliabl
process
control
viru
time
phagelik
particl
similar
physicochem
properti
wildtyp
bacteriophag
therefor
noth
prevent
use
phagelik
particl
process
control
virus
detect
rna
virus
food
matric
similarli
case
clinic
specimen
current
commerci
avail
system
process
control
food
matric
base
use
genet
modifi
mengoviru
process
control
viru
detect
hav
nov
food
matric
isot
stress
phagelik
particl
use
univers
process
control
virus
phagelik
particl
good
process
control
virus
detect
certain
type
rna
virus
gener
phagelik
particl
use
process
control
virus
detect
structur
similar
rna
small
ssrna
virus
icosahedr
close
mimic
physicochem
properti
rna
extract
step
therefor
phagelik
particl
good
process
control
virus
detect
hav
hev
nov
food
matric
howev
literatur
also
find
exampl
util
phagelik
particl
process
control
virus
detect
coronavirus
envelop
comparison
phagelik
particl
rel
larger
ssrna
virus
cheng
et
al
yu
et
al
therefor
research
alway
consid
suitabl
phagelik
particl
process
control
virus
regard
target
viru
detect
